This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ajou University Industry-Academic Cooperation Foundation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Eu-Gene Lih: Innovator in Biomedical Hydrogel Technology
Introduction
Eu-Gene Lih is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative hydrogel technologies. His work focuses on creating materials that enhance medical applications, particularly in tissue adhesion and regeneration.
Latest Patents
Eu-Gene Lih holds a patent for an "in situ-forming hydrogel for tissue adhesives and biomedical use thereof." This invention discloses a bioadhesive hydrogel that is formed through in situ crosslinking via an enzymatic reaction. The hydrogel boasts superior biocompatibility compared to conventional bioadhesive hydrogels. It also exhibits excellent mechanical strength and tissue adhesiveness, thanks to modifications with or without dopa derivatives. The hydrogel has a wide range of applications in the biomedical field, including use as bioadhesives, hemostats, implant substances for tissue regeneration, and carriers for delivering biologically active materials or drugs.
Career Highlights
Eu-Gene Lih is affiliated with the Ajou University Industry-Academic Cooperation Foundation, where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve medical treatments and patient outcomes.
Collaborations
He has collaborated with notable colleagues, including Yoon-Ki Joung and Ki-Dong Park, to further enhance the impact of his research in the biomedical sector.
Conclusion
Eu-Gene Lih's innovative work in hydrogel technology represents a significant advancement in biomedical applications. His contributions are paving the way for improved medical solutions that can benefit a wide range of patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile